Published in Medicine and Law Weekly, September 28th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cerus Corporation.
Report 1: Cerus Corporation (NASDAQ:CERS) announced financial results for the second quarter ended June 30, 2007.
Revenues for the second quarter of 2007 were $4.5 million, down from $6.5 million for the second quarter of 2006. Product revenues for the INTERCEPT Blood System increased to $1.7 million during the current quarter, up from $0.8 million during the second quarter of 2006. In contrast to the second quarter of 2006, when $4.2 million of revenue...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.